| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biology, Boston College, Chestnut Hill, Massachusetts 02167-3811 [J. A. E., M. G. M., T. N. S.]; VA Medical and Regional Office Center, White River Junction, Vermont 05009 [H. C. Y.]; and Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire 03755 [H. C. Y.]
The genes for cytidine monophospho-N-acetylneuraminic acid hydroxylase (NeuAc-H) and ß-1,4-N-acetylgalactosaminyl transferase (GalNAc-T)were examined using reverse transcription-PCR in two experimental mouse brain tumors, EPEN and CT-2A. NeuAc-H is required for the synthesis of gangliosides containing N-glycolylneuraminic acid, whereas GalNAc-T is required for the synthesis of ganglioside GM2. The genes were analyzed in solid tumors grown in vivo and in tumor cells grown in vitro. NeuGc-containing gangliosides are abundant in cells of the mouse immune system, including macrophages, but are undetectable in normal mouse brain. GM2 is expressed in both neural and nonneural mouse cells and tissues. The EPEN tumor cells synthesize only ganglioside GM3, whereas the CT-2A tumor cells synthesize GM3, GM2, GM1, and GD1a. NeuAc-H gene expression was detected in both solid tumors grown in vivo but was undetectable in either tumor cell line. The presence or absence of NeuAc-H gene expression in the tumor tissues and cells correlates with the presence or absence, respectively, of NeuGc-containing gangliosides. Differences in GalNAc-T gene expression between the solid tumors and the cultured tumor cells correlate with the expression of ganglioside GM2. The findings suggest that the differences in ganglioside biosynthetic gene expression between brain tumors grown in vivo and in vitro are associated with the presence or absence, respectively, of tumor-infiltrating host cells.
1 Supported by NIH Grant NS24826, the Boston College Research Expense Fund, and a VA Merit Review (to H. C. Y.).
2 To whom requests for reprints should be addressed. Phone: (617) 552-3563; Fax: (617) 552-2011; E-mail: seyfried@hermes.bc.edu.
Received 12/23/96. Accepted 2/17/97.
This article has been cited by other articles:
![]() |
M. G. Manfredi, S. Lim, K. P. Claffey, and T. N. Seyfried Gangliosides Influence Angiogenesis in an Experimental Mouse Brain Tumor Cancer Res., October 1, 1999; 59(20): 5392 - 5397. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ecsedy, H. C. Yohe, A. J. Bergeron, and T. N. Seyfried Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors J. Lipid Res., November 1, 1998; 39(11): 2218 - 2227. [Abstract] [Full Text] |
||||
![]() |
H.-H. Chou, H. Takematsu, S. Diaz, J. Iber, E. Nickerson, K. L. Wright, E. A. Muchmore, D. L. Nelson, S. T. Warren, and A. Varki A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence PNAS, September 29, 1998; 95(20): 11751 - 11756. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |